Table 6 Pharmacokinetic profiles and toxicity predictions of compounds.

From: Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3

Compound

Log papp

Log Kp

HIA (%)

Log PS

R-OCT2

Water solubility

Hepatotoxicity

Skin sensitization

ZINC01532028

0.011

− 2.74

100

− 3.068

NO

− 4.33

NO

NO

ZINC13378516

0.6

− 2.73

95.94

− 1.673

NO

− 4.3

YES

NO

ZINC14824819

0.989

− 2.76

91.51

− 1.897

NO

− 4.48

NO

NO

ZINC95913991

0.68

− 2.73

96.21

− 1.72

NO

− 4.32

NO

NO

ZINC13375652

1.25

− 2.91

94.45

− 1.969

NO

− 4.554

NO

NO

ZINC01619649

1.15

− 2.71

98.25

− 2.84

NO

− 4.81

NO

NO

ZINC14679204

1.018

− 2.733

92.46

− 2.094

NO

− 3.6

NO

NO

ZINC85491556

1.37

− 2.73

94.35

− 2.83

NO

− 3.34

NO

NO

ZINC85510542

1.242

− 2.83

95.78

− 1.92

NO

− 3.73

NO

NO